These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1382 related items for PubMed ID: 23314734

  • 1. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE, Würthwein G, Joachim B, Boddy AV, Krischke M, Fuhr U, Thompson PA, Jörger M, Schellens JH, Hempel G.
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M, Huitema AD, Meenhorst PL, Schellens JH, Beijnen JH.
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [Abstract] [Full Text] [Related]

  • 3. [Populational pharmacokinetics of doxorubicin applied to personalised its dosing in cancer patients].
    Escudero-Ortiz V, Ramón-López A, Duart MA, Pérez-Ruixo JJ, Valenzuela B.
    Farm Hosp; 2012 May; 36(4):282-91. PubMed ID: 22129650
    [Abstract] [Full Text] [Related]

  • 4. A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979).
    Callies S, de Alwis DP, Wright JG, Sandler A, Burgess M, Aarons L.
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):107-18. PubMed ID: 12647011
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.
    Bonate PL, Floret S, Bentzen C.
    Br J Clin Pharmacol; 2004 Aug; 58(2):142-55. PubMed ID: 15255796
    [Abstract] [Full Text] [Related]

  • 6. Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer.
    Völler S, Boos J, Krischke M, Würthwein G, Kontny NE, Boddy AV, Hempel G.
    Clin Pharmacokinet; 2015 Nov; 54(11):1139-49. PubMed ID: 25925711
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
    Kunarajah K, Hennig S, Norris RLG, Lobb M, Charles BG, Pinkerton R, Moore AS.
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):15-25. PubMed ID: 28444427
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients.
    Latz JE, Chaudhary A, Ghosh A, Johnson RD.
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):401-11. PubMed ID: 16322991
    [Abstract] [Full Text] [Related]

  • 9. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.
    van den Bongard HJ, Mathôt RA, van Tellingen O, Schellens JH, Beijnen JH.
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY, Rivory LP, Clarke SJ, McLachlan AJ.
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [Abstract] [Full Text] [Related]

  • 11. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
    Wihlm J, Limacher JM, Levêque D, Duclos B, Dufour P, Bergerat JP, Methlin G.
    Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetic investigation of actinomycin-D in children and young adults.
    Mondick JT, Gibiansky L, Gastonguay MR, Skolnik JM, Cole M, Veal GJ, Boddy AV, Adamson PC, Barrett JS.
    J Clin Pharmacol; 2008 Jan; 48(1):35-42. PubMed ID: 18094218
    [Abstract] [Full Text] [Related]

  • 14. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ, Pons G, Autret-Leca E, Allegaert K, Boccard E.
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D, Mondick JT, Jayaraman B, Thompson PA, Blaney SM, Bernstein M, Bond M, Champagne M, Fossler MJ, Barrett JS.
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.
    Hong Y, Shaw PJ, Nath CE, Yadav SP, Stephen KR, Earl JW, McLachlan AJ.
    Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetic analysis of meropenem in Japanese adult patients.
    Muro T, Sasaki T, Hosaka N, Umeda Y, Takemoto S, Yamamoto H, Kamimura H, Higuchi S, Karube Y.
    J Clin Pharm Ther; 2011 Apr; 36(2):230-6. PubMed ID: 21366653
    [Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H, Farré R, Soy D, Peraire C, Cendros JM, Pardo N, Torrent M, Domenech J, Mangues MA.
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [Abstract] [Full Text] [Related]

  • 19. Population pharmacokinetics of oral busulfan in children.
    Schiltmeyer B, Klingebiel T, Schwab M, Mürdter TE, Ritter CA, Jenke A, Ehninger G, Gruhn B, Würthwein G, Boos J, Hempel G.
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan kH, Leblond V, Lechat P.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.